Switzerland: Clinical Diagnostic Testing Advancement of DNA Based Sequencing: Roche Acquires Stratos Genomics

Editor: MA Alexander Stark

In order to advance the development of their nanopore sequencer, Roche has acquired Stratos Genomics, an early-stage sequencing technology company.

Related Vendors

Roche acquires Stratos Genomics to further develop DNA based sequencing for diagnostic use
Roche acquires Stratos Genomics to further develop DNA based sequencing for diagnostic use
(Source: Roche)

Basel/Switzerland — The acquisition of Stratos Genomics is to provide Roche access to the unique Sequencing by Expansion (SBX) technology that is to advance the nanopore sequencer. The Roche nanopore sequencer, once developed, will utilize a novel approach that combines electronic and biological components to sequence DNA for fast, flexible and cost-effective clinical diagnostic testing.

The addition of the SBX chemistry, once fully developed, is expected to provide the healthcare community an affordable, fast and flexible result, for multiple targeted clinical applications as well as whole exome and whole genome sequencing.

Stratos Genomics will continue operations in Seattle, Washington, US. Financial details of the agreement were not disclosed.

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy.

Unfold for details of your consent

(ID:46606576)